From Seattletimes · · 1m 30s
Trump admin moves to allow peptide drugs for wellness products
Trump administration advances plan to let pharmacies make unapproved peptide drugs popular with health advocates.
In brief
Trump administration advances plan to let pharmacies make unapproved peptide drugs popular with health advocates. Trump administration submits policy to allow specialty pharmacies to produce unregulated peptide injections favored by Health Secretary Robert F. Kennedy Jr. and wellness influencers. Originally reported…
Trump admin submits peptide policy
U.S. health officials move ahead with plan to let specialty pharmacies produce certain peptides popular among Health Secretary Robert F. Kennedy Jr. and wellness influencers.
Peptides are unregulated injections
Peptides are building blocks of proteins that trigger hormones for growth, metabolism and healing but lack FDA approval for most uses.
Kennedy pushes for peptide access
Kennedy previously declared FDA’s war on peptides would end and urged compounding pharmacies to sell gray market peptides from China.
Policy allows temporary peptide production
The White House filing lets pharmacies temporarily compound popular peptides like BPC-157 for muscle building and injury healing.
FDA previously restricted peptides
FDA listed BPC-157 and over a dozen peptides as too risky for pharmacy compounding due to contamination and allergic reactions.
Kennedy directs FDA to reconsider
Kennedy ordered FDA to review chemicals promoted by wellness influencers after a panel recommended dropping restrictions on six peptides.
Peptide market could reach $2 billion
Telehealth providers and Wall Street analysts estimate the unregulated peptide market could be worth $2 billion to $3 billion.
What to remember
Trump administration submits policy to allow specialty pharmacies to produce unregulated peptide injections favored by Health Secretary Robert F. Kennedy Jr. and wellness influencers.
